Economic implications of bivalirudin in the cardiac catheterization laboratory.

Abstract

More than 1.2 million percutaneous coronary intervention (PCI) procedures are performed each year in the United States, with average hospital costs of more than $10,000 per procedure. Despite ongoing improvements in device technology and adjunct pharmacology, both ischemic complications (eg, periprocedural myocardial infarction) and bleeding complications… (More)

Topics

  • Presentations referencing similar topics